Global urethral stricture treatment market, by Type (Posterior Urethral Stricture and Anterior Urethral Stricture), by Treatment (Urethral Dilation, Direct Vision Internal Urethrotomy (DVIU), Urethroplasty (Anastomotic Urethroplasty and Substitution Urethroplasty), and Others), by Disease Indication (Iatrogenic, Idiopathic, Infection-induced, Trauma, and Others), by End User (Hospitals, Ambulatory Surgical Center, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 1,326.0 million in 2019, and is expected to exhibit a CAGR of 6.0%, during the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.
Technological advancement for improving success rate and to lower pain with quick recovery are factors boosting growth of the market. Tissue engineering is one of the current trends in the treatment of urethral stricture. MukoCell, a graft for urethroplasty, developed by UroTiss Europe GmbH is proving as breakthrough option in tissue engineering. Increasing number of anterior urethral stricture cases is expected to be a major factor for growth of the market. According to the National Center for Biotechnology Information (NCBI), in 2019, around 1,242 bulbar urethral strictures were treated with 14 different surgical techniques in Italy. The overall success rate ranged from 87.5% to 14.3% using different techniques. Anterior urethral stricture are the most commonly occurring stricture and are caused due to infection or trauma leading to spongiofibrosis. Anterior urethral stricture mostly occurs in the bulbar urethra which represents around 46.9% of strictures, penile shares around 30.5%, penile & bulbar may represent 9.9%, and panurethral is least representing 4.9% strictures.
Browse 45 Market Data Tables and 37 Figures spread through 195 Pages and in-depth TOC on 'Global Urethral Stricture Treatment Market, by Type (Posterior Urethral Stricture and Anterior Urethral Stricture), by Treatment (Urethral Dilation, Direct Vision Internal Urethrotomy (DVIU), Urethroplasty (Anastomotic Urethroplasty and Substitution Urethroplasty), and Others), by Disease Indication (Iatrogenic, Idiopathic, Infection-induced, Trauma, and Others), by End User (Hospitals, Ambulatory Surgical Center, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027'
To know the latest trends and insights related to Global Urethral Stricture Treatment Market, click the link below:
Urethroplasty is a technique used for reconstruction of the infected section of the urethra. According to the Columbia University Irving Medical Center Department of Urology, Urethroplasty is considered as the ‘gold standard’ for urethral reconstruction, as it offers long-lasting results. Urethroplasty has transformed medical procedures by offering benefits such as lower chances of relapse of urethral stricture, reduced threat of inflammation in the area, and improved quality of life. According to the British Association of Urological Surgeons (BAUS) Limited, urethroplasty is the most preferred procedure globally, with a success rate of over 85.0%.
Moreover, adoption of inorganic strategies such as collaborations and acquisitions by major players in the urethral stricture treatment market are expected to drive growth of the market. For instance, in December 2018, Amecath Medical Technologies announced the expansion of its business in Paraguay in collaboration with Infinity International, a healthcare service provider based in Latin America to cater to the growing demand for urological disease treatment.
Furthermore, increasing product approvals by regulatory authorities is also expected to drive the market growth. For instance, in April 2018, Urotronic, Inc. received the U.S. Food and Drug Administration approval for Optilume drug-coated balloon (DCB) catheter for the treatment of male patients suffering from urethral strictures.
Key Takeaways of the Global Urethral Stricture Treatment Market:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.